DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism.

le Roca, J, Berger, J M, Harrison, S C, Wang, J C
Foilsithe 1996

Divalent metal cofactor binding in the kinetic folding trajectory of Escherichia coli ribonuclease HI.

le Goedken, E. R., Keck, J. L., Berger, J. M., Marqusee, S.
Foilsithe 2000

Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.

le Roca, J, Ishida, R, Berger, J M, Andoh, T, Wang, J C
Foilsithe 1994

Structure and function of an archaeal topoisomerase VI subunit with homology to the meiotic recombination factor Spo11.

le Nichols, M D, DeAngelis, K, Keck, J L, Berger, J M
Foilsithe 1999

Genetic dissection of pancreatic trypsin inhibitor.

le Goldenberg, D P, Berger, J M, Laheru, D A, Wooden, S, Zhang, J X
Foilsithe 1992

Histone chaperone Asf1 is required for histone H3 lysine 56 acetylation, a modification associated with S phase in mitosis and meiosis

le Recht, J., Tsubota, T., Tanny, J. C., Diaz, R. L., Berger, J. M., Zhang, X., Garcia, B. A., Shabanowitz, J., Burlingame, A. L., Hunt, D. F., Kaufman, P. D., Allis, C. D.
Foilsithe 2006

1692P SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria

le Berghoff, A.S., Gansterer, M., Bathke, A.C., Trutschnig, W., Hungerländer, P., Berger, J.M., Kreminger, J., Starzer, A., Schmidt, R., Lamm, W., Raderer, M., Gottlieb, A.D., Mauser, N.J., Preusser, M.
Foilsithe in Ann Oncol (2020)